EquityZen Growth Technology Fund II LLC - Series 8
Raised
$3M
Investors
15
Min Invest
$49,584
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund II LLC - Series 8 is a Delaware-based pooled investment fund filed by EquityZen Advisors LLC and Phil Haslett on March 21, 2025. The vehicle raised $2.9M from 15 investors under Rule 506(b) and 3(c) exemptions, with a $50K minimum investment. It is part of the EquityZen platform, which operates approximately 150 related EDGAR entities focused on private equity secondaries.
This Series offering follows the EquityZen platform's standard structure of discrete fund series vehicles targeting private company equity. The $50K minimum investment and 506(b) exemption align with typical sophisticated investor-focused private equity offerings, while the $193K average check size is consistent with mid-tier accredited investor participation in secondary market funds.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Phil Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. AltStreet analysis (summaries, flags, category context) is generated by Claude from this primary source data and reviewed for accuracy. Platform-provided information (if present) is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. EDGAR data is verified read-only — platforms may request factual corrections for demonstrable inaccuracies by contacting research@altstreet.investments. This page does not constitute investment advice.
